Sale!

DNAI1 Gene Primary Ciliary Dyskinesia Type 1 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The DNAI1 gene primary ciliary dyskinesia type 1 genetic test is a specialized diagnostic tool designed to identify mutations in the DNAI1 gene, which are associated with primary ciliary dyskinesia (PCD) type 1. This condition is a rare, genetic disorder that affects the cilia, leading to issues with respiratory function, fertility, and sometimes, organ laterality. Identifying mutations in the DNAI1 gene can confirm a diagnosis of PCD type 1, allowing for appropriate management and treatment strategies to be implemented.

The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in a laboratory setting. DNA Labs UAE offers this genetic test, providing a reliable service for diagnosing PCD type 1. The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results. Conducted in a state-of-the-art facility, the test is an important resource for individuals presenting symptoms of PCD or those with a family history of the condition, enabling early intervention and personalized care plans.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

DNAI1 Gene Primary ciliary dyskinesia type 1 Genetic Test

At DNA Labs UAE, we offer the DNAI1 Gene Primary ciliary dyskinesia type 1 Genetic Test for individuals suspected of having primary ciliary dyskinesia type 1. This genetic test helps in the diagnosis and management of this genetic disorder.

Test Components

  • Price: 4400.0 AED
  • Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
  • Report Delivery: 3 to 4 Weeks
  • Method: NGS Technology
  • Test Type: Ear Nose Throat Disorders
  • Doctor: ENT Doctor
  • Test Department: Genetics

Pre Test Information

Before undergoing the DNAI1 Gene Primary ciliary dyskinesia type 1 Genetic Test, it is important to provide the clinical history of the patient who is going for the test. Additionally, a genetic counseling session is recommended to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN37.

Test Details

The DNAI1 gene is associated with primary ciliary dyskinesia type 1, a genetic disorder that affects the function of cilia in the respiratory tract and other organs. Cilia are tiny hair-like structures that line the airways and help to move mucus and other substances out of the lungs.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular disorder or condition. In the case of primary ciliary dyskinesia type 1, NGS genetic testing can be used to identify variations or mutations in the DNAI1 gene that may be causing the disorder.

By identifying these genetic variations or mutations, NGS genetic testing can help with the diagnosis of primary ciliary dyskinesia type 1 and provide important information for treatment and management of the condition. It can also assist with genetic counseling and family planning for individuals and families affected by the disorder.

Test Name DNAI1 Gene Primary ciliary dyskinesia type 1 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PTPN23 Gene Ciliogenesis related disorder NGS Genetic DNA Test gene PTPN37
Test Details

The DNAI1 gene is associated with primary ciliary dyskinesia type 1, which is a genetic disorder that affects the function of cilia in the respiratory tract and other organs. Cilia are tiny hair-like structures that line the airways and help to move mucus and other substances out of the lungs.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously to identify genetic variations or mutations that may be associated with a particular disorder or condition. In the case of primary ciliary dyskinesia type 1, NGS genetic testing can be used to identify variations or mutations in the DNAI1 gene that may be causing the disorder.

By identifying these genetic variations or mutations, NGS genetic testing can help with the diagnosis of primary ciliary dyskinesia type 1 and provide important information for treatment and management of the condition. It can also help with genetic counseling and family planning for individuals and families affected by the disorder.